Skip to main content
CINQAIR 10 mg/mL injection, solution, concentrate by Teva Respiratory, LLC
CINQAIR, 10 mg/mL, injection, solution, concentrate Drug class: Interleukin-5 Antagonist. Available on prescription only. Listed by Teva Respiratory, LLC.
Prescription only

CINQAIR

Reslizumab

Listed by Teva Respiratory, LLC

Strength
10 mg/mL
Form
Injection, Solution, Concentrate
Route
Intravenous
Class
Interleukin-5 Antagonist

What it contains

  • Reslizumab 10 mg/mL

FDA record

Dosage form Injection, Solution, Concentrate
Route Intravenous
Drug class Interleukin-5 Antagonist
Approval route BLA — biologic licence
NDC code 59310-610
FDA application BLA761033
RxNorm concept 1746893
Package sizes listed 1
Marketed since April 2016

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.